Evaluating long-term development in children with Pyridoxine-Dependent Epilepsy
Official title: Standardized Evaluation of Long-term Neurocognitive Development of Children from Age 3 with Pyridoxine Dependent Epilepsy by Antiquitine Deficiency
Run by University Hospital, Angers · NCT06054347 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to see how children over 3 years old with Pyridoxine-Dependent Epilepsy develop their thinking and daily living skills over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital, Angers Government |
| Locations | 12 sites (Angers and 11 other locations) |
| Trial ID | NCT06054347 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 3 years and older diagnosed with Pyridoxine-Dependent Epilepsy due to a genetic mutation in the ALDH7A1 gene.
✕Probably not a fit
Patients who do not understand the French language may not benefit from this study due to the language requirements for participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the long-term neurocognitive development of children over the age of 3 who have Pyridoxine-Dependent Epilepsy due to antiquitine deficiency. Utilizing the Vineland II scale, the study will gather data through a semi-structured questionnaire completed by parents, providing insights into the patients' cognitive abilities and daily living skills. The research seeks to standardize the evaluation of cognitive development in this rare condition, especially in light of recent dietary recommendations that may influence outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of neurodevelopmental outcomes in children with Pyridoxine-Dependent Epilepsy.
How similar studies have gone: Very few studies have evaluated the cognitive development of these patients in a standardized way, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age above 3 years old * Pyridoxine dependent epilepsy genetic diagnosis (mutation in ALDH7A1 gene) * No objection of the patient or his legal representatives. Exclusion Criteria: * Poor understanding of French language.
Where it's running
-
CHU Angers
Angers, France Recruiting -
CHRU Morvan
Brest, France Recruiting -
CHU d'Estaing
Clermont-Ferrand, France Recruiting -
Hôpital Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
Hôpital Jeanne de Flandre
Lille, France Recruiting -
Hôpital de la Timone-Enfants
Marseille, France Recruiting
Show 6 more locations
-
CHU Gui de Chautiac
Montpeliier, France Recruiting -
Hôpital Necker-Enfants malades
Paris, France Recruiting -
CHU Toulouse
Toulouse, France Recruiting -
Hôpital Clocheville
Tours, France Recruiting -
Centre Hospitalier Universitaire de Besançon
Besançon, France Not yet recruiting -
Centre Hospitalier Saint Nazaire
Saint-Nazaire, France Not yet recruiting
Study contacts
- Principal investigator: Patrick VAN BOGAERT, PhD - MD — University Hospital, Angers
- Study coordinator: Patrick VAN BOGAERT, PhD - MD
- Email: Patrick.VanBogaert@chu-angers.fr
- Phone: 0033241354846
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postoperative Rectal Pain Relief With Ear Vagus Nerve Stimulation
This study tests whether stimulating the vagus nerve through an ear-based device can reduce pain after anal or rectal surgery.
-
Perineural Catheter for Hindfoot Surgery Pain Control
This study tests whether a continuous perineural catheter delivering local anesthetic after hindfoot surgery helps with pain more than standard care.
-
Screening for blood clots in adults with acute heart failure
This trial tests whether a guideline-based screening approach can detect pulmonary embolism in adults admitted with acute heart failure.
-
Long-term overwintering on the Kerguelen Islands and its effects on the immune system
This project will test how living as an overwintering team member on the Kerguelen Islands for about a year affects the immune system in healthy adults.
-
Intubation strategies for adults with acute hypoxemic respiratory failure
This trial will test two different rules for when to intubate adults with acute hypoxemic respiratory failure to see which approach keeps patients safer while avoiding unnecessary mechanical ventilation.
-
Changing infusion lines every 4 days versus every 7 days to prevent catheter infections in the ICU
This will test whether changing infusion lines every 7 days instead of every 4 days affects infection risk in adult ICU patients with central venous catheters.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.